Payment overview · 2025
General Payments
$13.76
1 reported records · 1 companies
Healthcare provider profile · identity verified
Peter A Macdonald, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · BIG RAPIDS, MI · NPI 1699797092
Verified facts
What the public records show
CMS Open Payments records show Peter A Macdonald, M.D. received $13.76 in general payments during 2025 across 1 reported records.
Takeda Pharmaceuticals U.S.A., Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $13.76 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $13.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EOHILIA Normalized: eohilia |
Drug | Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1188 | 356 |
| Lisinopril | Lisinopril | 824 | 234 |
| Amlodipine Besylate | Amlodipine Besylate | 551 | 164 |
| Losartan Potassium | Losartan Potassium | 467 | 141 |
| Levothyroxine Sodium | Levothyroxine Sodium | 434 | 130 |
| Omeprazole | Omeprazole | 348 | 108 |
| Metoprolol Tartrate | Metoprolol Tartrate | 327 | 98 |
| Hydrochlorothiazide | Hydrochlorothiazide | 312 | 99 |
| Metformin Hcl | Metformin Hcl | 290 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 282 | 90 |
| Gabapentin | Gabapentin | 280 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 195 | 65 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 193 | 66 |
| Simvastatin | Simvastatin | 177 | 51 |
| Furosemide | Furosemide | 160 | 55 |
| Eliquis | Apixaban | 156 | 38 |
| Potassium Chloride | Potassium Chloride | 152 | 48 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 131 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 128 | 64 |
| Carvedilol | Carvedilol | 122 | 37 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 120 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 120 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 119 | 40 |
| Pantoprazole Sodium | Pantoprazole Sodium | 115 | 37 |
| Montelukast Sodium | Montelukast Sodium | 107 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 43 |
| Allopurinol | Allopurinol | 101 | 34 |
| Trulicity | Dulaglutide | 101 | 26 |
| Sertraline Hcl | Sertraline Hcl | 100 | 29 |
| Mounjaro | Tirzepatide | 99 | 15 |
| Jardiance | Empagliflozin | 95 | 23 |
| Trazodone Hcl | Trazodone Hcl | 95 | 36 |
| Metformin Hcl Er | Metformin Hcl | 90 | 30 |
| Chlorthalidone | Chlorthalidone | 89 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 87 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 84 | 25 |
| Ezetimibe | Ezetimibe | 83 | 24 |
| Finasteride | Finasteride | 83 | 23 |
| Glipizide | Glipizide | 79 | 26 |
| Tramadol Hcl | Tramadol Hcl | 77 | 25 |
| Ibuprofen | Ibuprofen | 75 | 23 |
| Propranolol Hcl | Propranolol Hcl | 69 | 12 |
| Spironolactone | Spironolactone | 68 | 18 |
| Alendronate Sodium | Alendronate Sodium | 67 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 67 | 19 |
| Pregabalin | Pregabalin | 61 | 18 |
| Famotidine | Famotidine | 60 | 22 |
| Prednisone | Prednisone | 59 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 56 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 56 | 16 |
| Atenolol | Atenolol | 51 | 17 |
| Gemfibrozil | Gemfibrozil | 50 | 16 |
| Alprazolam | Alprazolam | 46 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 46 | 17 |
| Indapamide | Indapamide | 46 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 13 |
| Xarelto | Rivaroxaban | 43 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 42 | 13 |
| Ozempic | Semaglutide | 41 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 39 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Methocarbamol | Methocarbamol | 38 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 37 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 35 | suppressed |
| Olanzapine | Olanzapine | 35 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 34 | suppressed |
| Lansoprazole | Lansoprazole | 33 | 11 |
| Celecoxib | Celecoxib | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Meloxicam | Meloxicam | 27 | 14 |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 25 | 14 |
| Valsartan | Valsartan | 25 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 20 |
| Clonazepam | Clonazepam | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 11 |
| Glimepiride | Glimepiride | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Armour Thyroid | Thyroid,pork | 17 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Nystatin | Nystatin | 16 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | 11 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Mirtazapine | Mirtazapine | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.76 · 1 records | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error